Ivsins A, MacKinnon L, Bowles J, Slaunwhite A, Bardwell G Overdose prevention and housing: a qualitative study examining drug use, overdose risk, and access to safer supply in permanent supportive housing in Vancouver, Canada J Urban Health, 2022. PubMed

Socías ME, Wood E, Le Foll B, Lim R, Choi JC, Mok WY, Bruneau J, Rehm J, Wild TC, Bozinoff N, Hassan A, Jutras-Aswad D, OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial Addiction, 2022. PubMed

Moallef S, Salway T, Phanuphak N, Kivioja K, Pongruengphant S, Hayashi K The relationship between sexual and gender stigma and suicide attempt and ideation among LGBTQI + populations in Thailand: findings from a national survey Soc Psychiatry Psychiatr Epidemiol, 2022. PubMed

Macmadu A, Reddon H, Marshall BDL, Fairbairn N, Nolan S, Socías ME, Milloy MJ Crack cocaine use frequency is associated with HIV disease severity independent of antiretroviral therapy exposure: a prospective cohort study AIDS Behav, 2022. PubMed

Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Bruneau J, Fischer B, Rehm J, Wild TC, Wood E, Brissette S, Gagnon L, Fikowski J, Ledjiar O, Masse B, Socías ME, OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse Flexible buprenorphine/naloxone model of care for reducing opioid use in individuals with prescription-type opioid use disorder: an open-label, pragmatic, noninferiority randomized controlled trial Am J Psychiatry, 2022. PubMed

Bahji A, Milloy MJ, Bach P, Sociás ME Challenges and opportunities for further research involving the cannabis-to-opioid use transition Addiction, 2022. PubMed

Nolan S, Kelian S, Kerr T, Young S, Malmgren I, Ghafari C, Harrison S, Wood E, Lysyshyn M, Holliday E Harm reduction in the hospital: an overdose prevention site (OPS) at a Canadian hospital Drug Alcohol Depend, 2022. PubMed

Hong R, Brar R, Fairbairn N Supporting self-isolation for COVID-19 with "risk mitigation" prescribing and housing supports for people who use drugs: a case report J Addict Med, 2022. PubMed

Ivsins A, Fleming T, Barker A, Mansoor M, Thakarar K, Sue K, McNeil R The practice and embodiment of "goofballs": a qualitative study exploring the co-injection of methamphetamines and opioids Int J Drug Policy, 2022. PubMed

Pilarinos A, Kwa Y, Joe R, Thulien M, Buxton J, DeBeck K, Fast D Navigating opioid agonist therapy among young people who use illicit opioids in Vancouver, Canada Int J Drug Policy, 2022. PubMed